| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | KDM5A AIRE BRD3 SRCAP SCML2 ZZZ3 NCAPD2 SMARCA2 KMT2A PHF14 HDGFL2 PHIP CBX2 | 2.49e-09 | 265 | 110 | 13 | GO:0042393 |
| GeneOntologyMolecularFunction | histone modifying activity | BRPF3 SETD1B KMT2B KDM5A JADE2 SRCAP JARID2 SETDB1 SETBP1 KMT2A KDM1A | 5.59e-08 | 229 | 110 | 11 | GO:0140993 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.45e-07 | 44 | 110 | 6 | GO:0140938 | |
| GeneOntologyMolecularFunction | chromatin binding | ZC3H12A KDM5A AIRE BRD3 HMGA1 PHF21A JARID2 SETDB1 SCML2 CTCF ZC3H4 SMARCA2 KMT2A CDC6 CRAMP1 KDM1A CBX2 | 5.90e-07 | 739 | 110 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.02e-06 | 68 | 110 | 6 | GO:0016279 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.10e-06 | 206 | 110 | 9 | GO:0140030 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.20e-06 | 69 | 110 | 6 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.61e-06 | 71 | 110 | 6 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.95e-06 | 20 | 110 | 4 | GO:0042800 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 8.93e-06 | 8 | 110 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone reader activity | 1.19e-05 | 26 | 110 | 4 | GO:0140566 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.90e-05 | 10 | 110 | 3 | GO:0140999 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.14e-05 | 30 | 110 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.26e-05 | 103 | 110 | 6 | GO:0008276 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 2.37e-05 | 213 | 110 | 8 | GO:0008168 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.45e-05 | 31 | 110 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 2.52e-05 | 105 | 110 | 6 | GO:0008170 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.40e-05 | 224 | 110 | 8 | GO:0016741 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 4.70e-05 | 172 | 110 | 7 | GO:0008757 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 7.55e-05 | 41 | 110 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | demethylase activity | 9.99e-05 | 44 | 110 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 6.53e-04 | 31 | 110 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 7.18e-04 | 32 | 110 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 8.24e-04 | 8 | 110 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 1.06e-03 | 9 | 110 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.31e-03 | 86 | 110 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | unmethylated CpG binding | 1.31e-03 | 10 | 110 | 2 | GO:0045322 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.42e-03 | 88 | 110 | 4 | GO:0140034 | |
| GeneOntologyMolecularFunction | minor groove of adenine-thymine-rich DNA binding | 1.60e-03 | 11 | 110 | 2 | GO:0003680 | |
| GeneOntologyMolecularFunction | histone H4K8 acetyltransferase activity | 1.60e-03 | 11 | 110 | 2 | GO:0043996 | |
| GeneOntologyMolecularFunction | histone H4K5 acetyltransferase activity | 1.60e-03 | 11 | 110 | 2 | GO:0043995 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DLG5 KDM5A BRD3 HMGA1 SRCAP SHANK3 JARID2 ZZZ3 PIK3R1 SMARCA2 PHF14 HDGFL2 WNK3 KDM1A SCAI | 1.73e-03 | 1160 | 110 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H4K12 acetyltransferase activity | 1.91e-03 | 12 | 110 | 2 | GO:0043997 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.80e-03 | 51 | 110 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 3.01e-03 | 15 | 110 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | DLG5 KDM5A BRD3 HMGA1 SRCAP SHANK3 JARID2 ZZZ3 CTCF PIK3R1 SMARCA2 PHF14 HDGFL2 WNK3 KDM1A SCAI | 3.05e-03 | 1356 | 110 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 3.29e-03 | 54 | 110 | 3 | GO:0030159 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 3.47e-03 | 55 | 110 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | zinc ion binding | KMT2B KDM5A NR4A2 AIRE TRIP12 SHANK3 PIKFYVE SETDB1 ZZZ3 CTCF KMT2A PHF14 | 3.68e-03 | 891 | 110 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.78e-03 | 187 | 110 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 3.87e-03 | 17 | 110 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | DNA replication origin binding | 4.34e-03 | 18 | 110 | 2 | GO:0003688 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.43e-03 | 60 | 110 | 3 | GO:0034212 | |
| GeneOntologyBiologicalProcess | chromatin organization | FAM47A BRPF3 SETD1B KMT2B PHF20 KDM5A JADE2 BICRA FAM47C BRD3 HMGA1 SRCAP TRIP12 PHF21A JARID2 SETDB1 ZZZ3 CTCF SETBP1 MKI67 SMARCA2 KMT2A PHF14 HDGFL2 KDM1A CBX2 | 7.86e-13 | 896 | 109 | 26 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | FAM47A BRPF3 SETD1B KMT2B PHF20 KDM5A JADE2 BICRA FAM47C BRD3 HMGA1 SRCAP TRIP12 PHF21A JARID2 SETDB1 ZZZ3 CTCF SETBP1 MKI67 SMARCA2 KMT2A PHF14 HDGFL2 KDM1A CBX2 | 9.12e-12 | 999 | 109 | 26 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | FAM47A BRPF3 SETD1B KMT2B KDM5A JADE2 BICRA FAM47C BRD3 HMGA1 SRCAP TRIP12 JARID2 SETDB1 CTCF SETBP1 SMARCA2 KMT2A HDGFL2 KDM1A | 1.77e-09 | 741 | 109 | 20 | GO:0006338 |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 1.56e-08 | 55 | 109 | 7 | GO:0140718 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 2.47e-06 | 163 | 109 | 8 | GO:0031507 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 3.46e-06 | 44 | 109 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | FAM47A KMT2B KDM5A FAM47C TRIP12 JARID2 SETDB1 CTCF KMT2A KDM1A | 1.01e-05 | 330 | 109 | 10 | GO:0040029 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.25e-05 | 203 | 109 | 8 | GO:0045814 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SMIM22 CARMIL2 ABI3BP MYO5A SPTBN1 XRCC1 SHANK3 CCNF PIKFYVE TBC1D10C SETDB1 SH3PXD2B CTCF PIK3R1 NCAPD2 MKI67 SMARCA2 CDC6 PHIP WDR44 | 2.20e-05 | 1342 | 109 | 20 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 5.82e-05 | 40 | 109 | 4 | GO:1902275 | |
| GeneOntologyCellularComponent | chromatin | FAM47A BRPF3 PHF20 KDM5A JADE2 BICRA NR4A2 FAM47C BRD3 EBF1 HMGA1 XRCC1 SRCAP JARID2 SCML2 ZZZ3 ZSCAN1 SMARCA2 PHF14 SHLD3 KDM1A CBX2 | 6.67e-06 | 1480 | 109 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 4.54e-05 | 75 | 109 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | methyltransferase complex | 2.56e-04 | 108 | 109 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 5.56e-04 | 7 | 109 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 6.71e-04 | 33 | 109 | 3 | GO:0044665 | |
| HumanPheno | Abnormal nasal tip morphology | KMT2B BICRA SPTBN1 RREB1 SRCAP SHANK3 PHF21A JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SRRM2 PHIP KDM1A | 2.06e-07 | 386 | 48 | 16 | HP:0000436 |
| HumanPheno | Abnormal experience of reality | PMS2 SETD1B KMT2B SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 PHF21A CCNF JARID2 CTCF SETBP1 KMT2A SLC45A1 SRRM2 PHIP KDM1A | 2.25e-06 | 646 | 48 | 19 | HP:5200423 |
| HumanPheno | Short philtrum | SPTBN1 NR4A2 RREB1 SRCAP TRIP12 PHF21A JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 PHIP | 2.44e-06 | 253 | 48 | 12 | HP:0000322 |
| HumanPheno | Abnormal fear-induced behavior | PMS2 SETD1B KMT2B SPTBN1 NR4A2 RREB1 SRCAP TRIP12 PHF21A CCNF CTCF SETBP1 KMT2A SLC45A1 SRRM2 PHIP KDM1A | 3.66e-06 | 538 | 48 | 17 | HP:0100852 |
| HumanPheno | Deeply set eye | KMT2B BICRA SPTBN1 SRCAP SHANK3 JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SRRM2 PHIP | 4.13e-06 | 266 | 48 | 12 | HP:0000490 |
| HumanPheno | Maladaptive fear-related cognitions | PMS2 SETD1B KMT2B SPTBN1 NR4A2 RREB1 SRCAP TRIP12 PHF21A CCNF CTCF SETBP1 KMT2A SLC45A1 SRRM2 PHIP | 4.27e-06 | 483 | 48 | 16 | HP:5200230 |
| HumanPheno | Anxiety | PMS2 SETD1B KMT2B SPTBN1 NR4A2 RREB1 SRCAP TRIP12 PHF21A CCNF CTCF SETBP1 KMT2A SLC45A1 SRRM2 PHIP | 4.27e-06 | 483 | 48 | 16 | HP:0000739 |
| HumanPheno | Abnormal judgment | PMS2 SETD1B KMT2B SPTBN1 NR4A2 RREB1 SRCAP TRIP12 PHF21A CCNF CTCF SETBP1 KMT2A SLC45A1 SRRM2 PHIP | 1.01e-05 | 516 | 48 | 16 | HP:5200401 |
| HumanPheno | Thick eyebrow | 1.02e-05 | 154 | 48 | 9 | HP:0000574 | |
| HumanPheno | Bulbous nose | KMT2B BICRA SPTBN1 RREB1 SRCAP SHANK3 JARID2 SMARCA2 KMT2A SRRM2 | 1.29e-05 | 201 | 48 | 10 | HP:0000414 |
| HumanPheno | Hypertelorism | RPGRIP1 BICRA COL27A1 SPTBN1 NR4A2 RREB1 TRIP12 SHANK3 STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SLC45A1 PHIP WNK3 KDM1A | 2.42e-05 | 830 | 48 | 20 | HP:0000316 |
| HumanPheno | Generalized hypertrichosis | 2.68e-05 | 7 | 48 | 3 | HP:0004554 | |
| HumanPheno | Abnormal earlobe morphology | 3.40e-05 | 137 | 48 | 8 | HP:0000363 | |
| HumanPheno | Abnormal 5th finger morphology | RPGRIP1 KMT2B COL27A1 SRCAP SHANK3 PHF21A JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A CDC6 PHIP KDM1A | 3.87e-05 | 509 | 48 | 15 | HP:0004207 |
| HumanPheno | Clinodactyly | KMT2B COL27A1 SRCAP TRIP12 SHANK3 PHF21A STAMBP SH3PXD2B CTCF PIK3R1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 3.90e-05 | 574 | 48 | 16 | HP:0030084 |
| HumanPheno | Radial deviation of finger | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF PIK3R1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 3.98e-05 | 448 | 48 | 14 | HP:0009466 |
| HumanPheno | Narrow palpebral fissure | 4.58e-05 | 71 | 48 | 6 | HP:0045025 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF PIK3R1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 4.84e-05 | 456 | 48 | 14 | HP:0009485 |
| HumanPheno | Abnormality of globe location | RPGRIP1 KMT2B BICRA COL27A1 SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SLC45A1 SRRM2 PHIP WNK3 KDM1A | 6.10e-05 | 1122 | 48 | 23 | HP:0100886 |
| HumanPheno | Abnormal finger morphology | RPGRIP1 SETD1B KMT2B BICRA SPEG COL27A1 SPTBN1 NR4A2 AIRE DNAAF11 RREB1 SRCAP SHANK3 PHF21A STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 6.55e-05 | 1385 | 48 | 26 | HP:0001167 |
| HumanPheno | Synophrys | 6.73e-05 | 195 | 48 | 9 | HP:0000664 | |
| HumanPheno | Deviation of finger | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 7.26e-05 | 537 | 48 | 15 | HP:0004097 |
| HumanPheno | Autistic behavior | SETD1B KMT2B BICRA SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 CTCF SETBP1 NCAPD2 SMARCA2 KMT2A SRRM2 | 8.04e-05 | 678 | 48 | 17 | HP:0000729 |
| HumanPheno | Facial hypertrichosis | 1.03e-04 | 206 | 48 | 9 | HP:0002219 | |
| HumanPheno | Abnormal external nose morphology | RPGRIP1 KMT2B BICRA COL27A1 SPTBN1 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SRRM2 PHIP KDM1A | 1.04e-04 | 916 | 48 | 20 | HP:0010938 |
| HumanPheno | Hyperactivity | PMS2 KMT2B SPTBN1 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 CTCF SETBP1 SMARCA2 KMT2A SRRM2 PHIP | 1.13e-04 | 558 | 48 | 15 | HP:0000752 |
| HumanPheno | Deviation of the hand or of fingers of the hand | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 1.28e-04 | 564 | 48 | 15 | HP:0009484 |
| HumanPheno | Abnormal midface morphology | RPGRIP1 SETD1B KMT2B BICRA COL27A1 SPTBN1 RREB1 SRCAP SHANK3 STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 CDC6 | 1.30e-04 | 704 | 48 | 17 | HP:0000309 |
| HumanPheno | Low hanging columella | 1.60e-04 | 56 | 48 | 5 | HP:0009765 | |
| HumanPheno | 2-3 toe syndactyly | 1.74e-04 | 90 | 48 | 6 | HP:0004691 | |
| HumanPheno | Abnormality of the philtrum | SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SLC45A1 CDC6 SRRM2 PHIP | 1.91e-04 | 726 | 48 | 17 | HP:0000288 |
| HumanPheno | Medial flaring of the eyebrow | 2.24e-04 | 228 | 48 | 9 | HP:0010747 | |
| HumanPheno | Abnormal facial shape | DLG5 SETD1B KMT2B SPEG SPTBN1 NR4A2 CCDC115 RREB1 SRCAP SHANK3 PHF21A STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SLC45A1 CDC6 PHIP KDM1A | 2.42e-04 | 1221 | 48 | 23 | HP:0001999 |
| HumanPheno | Aplasia/Hypoplasia involving the nose | BICRA SPTBN1 SRCAP TRIP12 PHF21A STAMBP CTCF PIK3R1 SETBP1 SMARCA2 KMT2A PHIP | 2.46e-04 | 401 | 48 | 12 | HP:0009924 |
| HumanPheno | Abnormal columella morphology | 2.63e-04 | 97 | 48 | 6 | HP:0009929 | |
| HumanPheno | Pointed chin | 2.68e-04 | 138 | 48 | 7 | HP:0000307 | |
| HumanPheno | Diagnostic behavioral phenotype | SETD1B KMT2B BICRA SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 CTCF SETBP1 NCAPD2 SMARCA2 KMT2A SRRM2 | 2.71e-04 | 747 | 48 | 17 | HP:0025783 |
| HumanPheno | Abnormality of the chin | BICRA SPTBN1 SRCAP TRIP12 SHANK3 JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 SRRM2 | 2.96e-04 | 409 | 48 | 12 | HP:0000306 |
| HumanPheno | Tapered finger | 3.05e-04 | 141 | 48 | 7 | HP:0001182 | |
| HumanPheno | Attention deficit hyperactivity disorder | PMS2 KMT2B SPTBN1 RREB1 SRCAP PHF21A JARID2 CTCF SETBP1 SMARCA2 SRRM2 PHIP | 3.24e-04 | 413 | 48 | 12 | HP:0007018 |
| HumanPheno | Joint contracture of the 5th finger | 3.30e-04 | 15 | 48 | 3 | HP:0009183 | |
| HumanPheno | Epicanthus | KMT2B BICRA RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 CTCF PIK3R1 SMARCA2 KMT2A SRRM2 PHIP WNK3 | 3.32e-04 | 614 | 48 | 15 | HP:0000286 |
| HumanPheno | Abnormality of globe location or size | RPGRIP1 KMT2B BICRA COL27A1 SPTBN1 NR4A2 RREB1 SRCAP TRIP12 SHANK3 STAMBP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SLC45A1 SRRM2 PHIP WNK3 KDM1A | 3.33e-04 | 1246 | 48 | 23 | HP:0000489 |
| HumanPheno | Abnormal hand morphology | RPGRIP1 DLG5 KMT2B BICRA COL27A1 NR4A2 RREB1 SRCAP SHANK3 PHF21A STAMBP SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A CDC6 PHIP WNK3 KDM1A | 3.61e-04 | 1082 | 48 | 21 | HP:0005922 |
| HumanPheno | Large earlobe | 3.65e-04 | 37 | 48 | 4 | HP:0009748 | |
| HumanPheno | Clinodactyly of the 5th finger | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF SMARCA2 KMT2A CDC6 PHIP KDM1A | 3.79e-04 | 420 | 48 | 12 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF SMARCA2 KMT2A CDC6 PHIP KDM1A | 3.87e-04 | 421 | 48 | 12 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF SMARCA2 KMT2A CDC6 PHIP KDM1A | 3.87e-04 | 421 | 48 | 12 | HP:0009179 |
| HumanPheno | Exaggerated cupid's bow | 4.05e-04 | 38 | 48 | 4 | HP:0002263 | |
| HumanPheno | Long fingers | SETD1B SPEG NR4A2 RREB1 PHF21A CTCF SMARCA2 KMT2A PHIP KDM1A | 4.47e-04 | 306 | 48 | 10 | HP:0100807 |
| HumanPheno | Full cheeks | 4.64e-04 | 151 | 48 | 7 | HP:0000293 | |
| HumanPheno | Downslanted palpebral fissures | SETD1B BICRA NR4A2 CCDC115 RREB1 JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SLC45A1 KDM1A | 4.86e-04 | 497 | 48 | 13 | HP:0000494 |
| HumanPheno | Thin vermilion border | SPTBN1 SRCAP TRIP12 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SLC45A1 SRRM2 PHIP KDM1A | 5.01e-04 | 433 | 48 | 12 | HP:0000233 |
| HumanPheno | Prominent forehead | COL27A1 SRCAP JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 KMT2A KDM1A | 6.10e-04 | 261 | 48 | 9 | HP:0011220 |
| HumanPheno | Broad nasal tip | 6.34e-04 | 159 | 48 | 7 | HP:0000455 | |
| HumanPheno | Abnormal nasal septum morphology | 6.58e-04 | 115 | 48 | 6 | HP:0000419 | |
| HumanPheno | Short attention span | PMS2 KMT2B SPTBN1 RREB1 SRCAP PHF21A JARID2 CTCF SETBP1 SMARCA2 KMT2A SRRM2 PHIP | 7.11e-04 | 517 | 48 | 13 | HP:0000736 |
| HumanPheno | Finger clinodactyly | KMT2B COL27A1 SRCAP SHANK3 PHF21A SH3PXD2B CTCF SMARCA2 KMT2A CDC6 PHIP KDM1A | 7.40e-04 | 452 | 48 | 12 | HP:0040019 |
| HumanPheno | Slanting of the palpebral fissure | SETD1B BICRA SPTBN1 NR4A2 CCDC115 RREB1 TRIP12 JARID2 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SLC45A1 PHIP KDM1A | 7.82e-04 | 739 | 48 | 16 | HP:0200006 |
| HumanPheno | Abnormal eyelid morphology | SETD1B KMT2B MYO5A BICRA SPTBN1 NR4A2 CCDC115 RREB1 SRCAP TRIP12 SHANK3 PHF21A JARID2 SH3PXD2B CTCF PIK3R1 SETBP1 SMARCA2 KMT2A SLC45A1 SRRM2 PHIP WNK3 KDM1A | 7.90e-04 | 1408 | 48 | 24 | HP:0000492 |
| HumanPheno | Reduced attention regulation | PMS2 KMT2B SPTBN1 RREB1 SRCAP PHF21A JARID2 CTCF SETBP1 SMARCA2 KMT2A SRRM2 PHIP | 8.38e-04 | 526 | 48 | 13 | HP:5200044 |
| HumanPheno | Triangular face | 8.50e-04 | 167 | 48 | 7 | HP:0000325 | |
| HumanPheno | Protruding ear | 8.75e-04 | 219 | 48 | 8 | HP:0000411 | |
| HumanPheno | Thin upper lip vermilion | SPTBN1 SRCAP TRIP12 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SRRM2 KDM1A | 1.00e-03 | 339 | 48 | 10 | HP:0000219 |
| HumanPheno | Thin lips | SPTBN1 SRCAP TRIP12 SH3PXD2B CTCF SETBP1 SMARCA2 KMT2A SRRM2 KDM1A | 1.00e-03 | 339 | 48 | 10 | HP:0000213 |
| HumanPheno | Constipation | PMS2 KMT2B BICRA SPTBN1 NR4A2 RREB1 SRCAP CTCF SMARCA2 KMT2A PHIP KDM1A | 1.09e-03 | 472 | 48 | 12 | HP:0002019 |
| HumanPheno | Long eyelashes | 1.20e-03 | 129 | 48 | 6 | HP:0000527 | |
| HumanPheno | Hypermetropia | 1.24e-03 | 288 | 48 | 9 | HP:0000540 | |
| HumanPheno | Syndactyly | KMT2B BICRA NR4A2 SHANK3 PHF21A JARID2 SBF1 CTCF SETBP1 KMT2A PHIP | 1.36e-03 | 417 | 48 | 11 | HP:0001159 |
| Domain | AT_hook | 1.43e-12 | 27 | 104 | 8 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.43e-12 | 27 | 104 | 8 | IPR017956 | |
| Domain | PHD | 3.35e-10 | 75 | 104 | 9 | PF00628 | |
| Domain | Znf_PHD-finger | 5.39e-10 | 79 | 104 | 9 | IPR019787 | |
| Domain | Znf_FYVE_PHD | BRPF3 KMT2B PHF20 KDM5A JADE2 AIRE PHF21A PIKFYVE KMT2A PHF14 BSN | 5.87e-10 | 147 | 104 | 11 | IPR011011 |
| Domain | PHD | 1.59e-09 | 89 | 104 | 9 | SM00249 | |
| Domain | Znf_PHD | 1.94e-09 | 91 | 104 | 9 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.86e-09 | 95 | 104 | 9 | PS50016 | |
| Domain | ZF_PHD_1 | 3.14e-09 | 96 | 104 | 9 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 7.23e-08 | 65 | 104 | 7 | IPR019786 | |
| Domain | BROMODOMAIN_2 | 9.89e-08 | 41 | 104 | 6 | PS50014 | |
| Domain | Bromodomain | 1.15e-07 | 42 | 104 | 6 | IPR001487 | |
| Domain | BROMO | 1.15e-07 | 42 | 104 | 6 | SM00297 | |
| Domain | - | 1.15e-07 | 42 | 104 | 6 | 1.20.920.10 | |
| Domain | EPHD | 1.19e-07 | 22 | 104 | 5 | PS51805 | |
| Domain | Bromodomain_CS | 2.91e-07 | 26 | 104 | 5 | IPR018359 | |
| Domain | HMGI/Y_DNA-bd_CS | 7.36e-07 | 31 | 104 | 5 | IPR000637 | |
| Domain | Post-SET_dom | 1.57e-06 | 16 | 104 | 4 | IPR003616 | |
| Domain | PostSET | 1.57e-06 | 16 | 104 | 4 | SM00508 | |
| Domain | AT_hook | 1.57e-06 | 16 | 104 | 4 | PF02178 | |
| Domain | POST_SET | 1.57e-06 | 16 | 104 | 4 | PS50868 | |
| Domain | BROMODOMAIN_1 | 1.84e-06 | 37 | 104 | 5 | PS00633 | |
| Domain | Bromodomain | 2.11e-06 | 38 | 104 | 5 | PF00439 | |
| Domain | MeTrfase_trithorax | 3.07e-05 | 2 | 104 | 2 | IPR016569 | |
| Domain | - | BRPF3 KMT2B PHF20 KDM5A JADE2 AIRE PHF21A PIKFYVE KMT2A PHF14 BSN | 4.10e-05 | 449 | 104 | 11 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | BRPF3 KMT2B PHF20 KDM5A JADE2 AIRE PHF21A PIKFYVE KMT2A PHF14 BSN | 5.01e-05 | 459 | 104 | 11 | IPR013083 |
| Domain | SET | 7.84e-05 | 41 | 104 | 4 | PF00856 | |
| Domain | SET | 1.24e-04 | 46 | 104 | 4 | SM00317 | |
| Domain | SET_dom | 1.72e-04 | 50 | 104 | 4 | IPR001214 | |
| Domain | SET | 1.72e-04 | 50 | 104 | 4 | PS50280 | |
| Domain | HSA | 1.83e-04 | 4 | 104 | 2 | SM00573 | |
| Domain | FAM47 | 1.83e-04 | 4 | 104 | 2 | PF14642 | |
| Domain | HSA | 1.83e-04 | 4 | 104 | 2 | PS51204 | |
| Domain | FAM47 | 1.83e-04 | 4 | 104 | 2 | IPR032743 | |
| Domain | HSA_dom | 1.83e-04 | 4 | 104 | 2 | IPR014012 | |
| Domain | HSA | 1.83e-04 | 4 | 104 | 2 | PF07529 | |
| Domain | FYrich_C | 3.04e-04 | 5 | 104 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.04e-04 | 5 | 104 | 2 | IPR003888 | |
| Domain | FYRC | 3.04e-04 | 5 | 104 | 2 | SM00542 | |
| Domain | FYRN | 3.04e-04 | 5 | 104 | 2 | SM00541 | |
| Domain | zf-C5HC2 | 3.04e-04 | 5 | 104 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 3.04e-04 | 5 | 104 | 2 | IPR004198 | |
| Domain | FYRN | 3.04e-04 | 5 | 104 | 2 | PF05964 | |
| Domain | FYRC | 3.04e-04 | 5 | 104 | 2 | PF05965 | |
| Domain | FYRC | 3.04e-04 | 5 | 104 | 2 | PS51543 | |
| Domain | FYRN | 3.04e-04 | 5 | 104 | 2 | PS51542 | |
| Domain | C2H2_Znf_fam | 3.12e-04 | 24 | 104 | 3 | IPR027775 | |
| Domain | EPL1 | 8.41e-04 | 8 | 104 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 8.41e-04 | 8 | 104 | 2 | IPR019542 | |
| Domain | JmjN | 1.34e-03 | 10 | 104 | 2 | SM00545 | |
| Domain | JmjN | 1.34e-03 | 10 | 104 | 2 | PF02375 | |
| Domain | JMJN | 1.34e-03 | 10 | 104 | 2 | PS51183 | |
| Domain | JmjN | 1.34e-03 | 10 | 104 | 2 | IPR003349 | |
| Domain | SH3_2 | 1.36e-03 | 86 | 104 | 4 | PF07653 | |
| Domain | SH3_2 | 1.36e-03 | 86 | 104 | 4 | IPR011511 | |
| Domain | ZF_CXXC | 1.63e-03 | 11 | 104 | 2 | PS51058 | |
| Domain | Znf_CXXC | 1.63e-03 | 11 | 104 | 2 | IPR002857 | |
| Domain | zf-CXXC | 1.63e-03 | 11 | 104 | 2 | PF02008 | |
| Domain | uDENN | 2.68e-03 | 14 | 104 | 2 | SM00800 | |
| Domain | SANT | 2.72e-03 | 50 | 104 | 3 | SM00717 | |
| Domain | SANT/Myb | 3.04e-03 | 52 | 104 | 3 | IPR001005 | |
| Domain | - | 3.08e-03 | 15 | 104 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 3.08e-03 | 15 | 104 | 2 | SM00501 | |
| Domain | ARID_dom | 3.08e-03 | 15 | 104 | 2 | IPR001606 | |
| Domain | ARID | 3.08e-03 | 15 | 104 | 2 | PS51011 | |
| Domain | uDENN | 3.08e-03 | 15 | 104 | 2 | PF03456 | |
| Domain | ARID | 3.08e-03 | 15 | 104 | 2 | PF01388 | |
| Domain | DENN | 3.50e-03 | 16 | 104 | 2 | SM00799 | |
| Domain | DENN | 3.50e-03 | 16 | 104 | 2 | PF02141 | |
| Domain | dDENN | 3.50e-03 | 16 | 104 | 2 | PF03455 | |
| Domain | UDENN | 3.50e-03 | 16 | 104 | 2 | PS50946 | |
| Domain | DDENN | 3.50e-03 | 16 | 104 | 2 | PS50947 | |
| Domain | dDENN | 3.50e-03 | 16 | 104 | 2 | SM00801 | |
| Domain | dDENN_dom | 3.50e-03 | 16 | 104 | 2 | IPR005112 | |
| Domain | uDENN_dom | 3.50e-03 | 16 | 104 | 2 | IPR005113 | |
| Domain | DENN | 3.50e-03 | 16 | 104 | 2 | PS50211 | |
| Domain | DENN_dom | 3.50e-03 | 16 | 104 | 2 | IPR001194 | |
| Domain | ZF_C3H1 | 4.14e-03 | 58 | 104 | 3 | PS50103 | |
| Domain | PWWP | 5.47e-03 | 20 | 104 | 2 | SM00293 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 SETD1B KMT2B PHF20 KDM5A JADE2 PHF21A SETDB1 ZZZ3 SMARCA2 KMT2A KDM1A BRWD1 | 3.84e-09 | 272 | 80 | 13 | M29619 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | BRPF3 SETD1B KMT2B PHF20 KDM5A JADE2 PHF21A SETDB1 KMT2A KDM1A BRWD1 | 3.93e-09 | 175 | 80 | 11 | MM14941 |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.25e-06 | 38 | 80 | 5 | MM17073 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 3.74e-06 | 42 | 80 | 5 | M48018 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.18e-05 | 136 | 80 | 7 | MM14848 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 3.28e-05 | 65 | 80 | 5 | M39374 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 9.42e-05 | 254 | 80 | 8 | M27131 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 1.31e-04 | 46 | 80 | 4 | MM14933 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KMT2B KDM5A BRD3 XRCC1 MCM10 RREB1 SRCAP TRIP12 SCML2 MKI67 KMT2A PHF14 NOP2 HDGFL2 PHIP KDM1A CBX2 BRWD1 | 1.53e-12 | 608 | 114 | 18 | 36089195 |
| Pubmed | BRPF3 KDM5A BICRA NOL12 GPATCH2 ZKSCAN2 BRD3 RREB1 SRCAP MAST2 PHF21A SETDB1 ZZZ3 CTCF ZC3H4 PIK3R1 SMARCA2 FOXL2NB SRRM2 PHIP KDM1A BRWD1 | 1.24e-11 | 1116 | 114 | 22 | 31753913 | |
| Pubmed | 1.46e-10 | 75 | 114 | 8 | 25593309 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KMT2B PHF20 KDM5A BRD3 HMGA1 XRCC1 RREB1 SRCAP TRIP12 PHF21A SCML2 ZZZ3 CTCF MKI67 KMT2A INTS9 PHF14 CDC6 SRRM2 NOP2 HDGFL2 KDM1A | 2.08e-10 | 1294 | 114 | 22 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B KDM5A SPTBN1 BRD3 HMGA1 RREB1 TRIP12 SCML2 ZC3H4 EIF4B MKI67 SMARCA2 KMT2A PHF14 SRRM2 NOP2 WDR44 | 6.74e-10 | 774 | 114 | 17 | 15302935 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PMS2 WDR46 XRCC1 SRCAP SCML2 ZC3H4 NCAPD2 MKI67 KMT2A INTS9 SRRM2 NOP2 | 1.47e-09 | 341 | 114 | 12 | 32971831 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BICRA HMGA1 XRCC1 RREB1 TRIP12 SCML2 ZZZ3 CTCF ZC3H4 EIF4B MKI67 KMT2A PHF14 SRRM2 NOP2 HDGFL2 PHIP CBX2 | 2.23e-09 | 954 | 114 | 18 | 36373674 |
| Pubmed | MYO5A SPTBN1 WDR46 TRIP12 SBF1 CTCF NCAPD2 MKI67 SMARCA2 KMT2A SRRM2 NOP2 PHIP KDM1A | 3.28e-08 | 653 | 114 | 14 | 22586326 | |
| Pubmed | 3.44e-08 | 57 | 114 | 6 | 18022353 | ||
| Pubmed | KMT2B MYO5A KDM5A BICRA SPTBN1 MRPS35 XRCC1 RREB1 SRCAP PHF21A SETDB1 ZZZ3 CTCF MKI67 SMARCA2 KMT2A SRRM2 NOP2 KDM1A CBX2 | 3.98e-08 | 1429 | 114 | 20 | 35140242 | |
| Pubmed | 7.65e-08 | 13 | 114 | 4 | 24619213 | ||
| Pubmed | DLG5 REPS1 KMT2B MYO5A KDM5A MRPS35 BRD3 XRCC1 JARID2 SCML2 SBF1 CTCF EIF4B NCAPD2 SMARCA2 KMT2A INTS9 PHF14 HDGFL2 KDM1A | 8.47e-08 | 1497 | 114 | 20 | 31527615 | |
| Pubmed | JADE2 NR4A2 OSR2 BRD3 EBF1 PHF21A PIKFYVE ZZZ3 ZFP41 MKI67 SMARCA2 KMT2A PHF14 PHIP | 9.02e-08 | 709 | 114 | 14 | 22988430 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.10e-07 | 69 | 114 | 6 | 28481362 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | GPATCH2 HMGA1 MAST2 NPHP4 KBTBD7 ZZZ3 SBF1 ZC3H4 EIF4B SRRM2 CBX2 | 1.48e-07 | 420 | 114 | 11 | 28065597 |
| Pubmed | DLG5 BRPF3 NYAP2 JADE2 PHF21A SBF1 ZC3H4 SETBP1 NCAPD2 BSN CRAMP1 KDM1A | 1.84e-07 | 529 | 114 | 12 | 14621295 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | BICRA BRD3 XRCC1 TRIP12 SCML2 CTCF MKI67 SMARCA2 KMT2A INTS9 SRRM2 PHIP | 1.99e-07 | 533 | 114 | 12 | 30554943 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.46e-07 | 349 | 114 | 10 | 25665578 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KMT2B KDM5A BICRA RREB1 PHF21A ZZZ3 MKI67 SMARCA2 KMT2A KDM1A | 2.59e-07 | 351 | 114 | 10 | 38297188 |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 25561738 | ||
| Pubmed | PHF20 KDM5A AIRE BRD3 EBF1 HMGA1 SRCAP PHF21A JARID2 CTCF ZFP41 SMARCA2 PHF14 CBX2 | 4.37e-07 | 808 | 114 | 14 | 20412781 | |
| Pubmed | DLG5 PMS2 REPS1 SH3PXD2B SCML2 CTCF ZC3H4 SMARCA2 INTS9 SRRM2 HDGFL2 | 4.70e-07 | 472 | 114 | 11 | 38943005 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 6.28e-07 | 21 | 114 | 4 | 27626377 | |
| Pubmed | NYAP2 MYO5A KDM5A SPTBN1 SHANK3 SH3PXD2B SBF1 GPR158 CTCF ZC3H4 SH3D19 BSN NOP2 WNK3 KDM1A | 6.29e-07 | 963 | 114 | 15 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 SETD1B REPS1 KMT2B BICRA SPEG SRCAP MAST2 NPHP4 PIKFYVE SH3PXD2B SBF1 NCAPD2 SLC45A1 CRAMP1 CBX2 | 6.75e-07 | 1105 | 114 | 16 | 35748872 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1B KMT2B PHF20 RREB1 TRIP12 JARID2 ZZZ3 KMT2A KDM1A SCAI CBX2 | 7.49e-07 | 495 | 114 | 11 | 27705803 |
| Pubmed | 9.17e-07 | 157 | 114 | 7 | 30186101 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 CARMIL2 KDM5A SPTBN1 MAST2 TRIP12 DENND2B SH3PXD2B SBF1 SH3D19 EIF4B KMT2A SRRM2 WNK3 | 9.27e-07 | 861 | 114 | 14 | 36931259 |
| Pubmed | 1.08e-06 | 233 | 114 | 8 | 37704626 | ||
| Pubmed | RPGRIP1 PMS2 KMT2B EBF1 HMGA1 MAST2 SEMA4G ZC3H4 PIK3R1 ZFP41 NCAPD2 KMT2A BSN HDGFL2 CBX2 | 1.08e-06 | 1006 | 114 | 15 | 15226823 | |
| Pubmed | 1.20e-06 | 103 | 114 | 6 | 32744500 | ||
| Pubmed | 1.48e-06 | 329 | 114 | 9 | 17474147 | ||
| Pubmed | DLG5 PMS2 BRD3 XRCC1 MCM10 SRCAP TRIP12 KMT2A NOP2 PHIP KDM1A CBX2 | 1.48e-06 | 645 | 114 | 12 | 25281560 | |
| Pubmed | 1.90e-06 | 8 | 114 | 3 | 22266653 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 1.90e-06 | 8 | 114 | 3 | 23130995 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1B GPATCH2 SRCAP TRIP12 SETDB1 SBF1 MKI67 SMARCA2 NOP2 KDM1A | 2.00e-06 | 440 | 114 | 10 | 34244565 |
| Pubmed | REPS1 KMT2B SRCAP SH3PXD2B SCML2 ZZZ3 SH3D19 NCAPD2 KMT2A KDM1A WDR44 | 2.04e-06 | 549 | 114 | 11 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | REPS1 HMGA1 SRCAP PHF21A SCML2 CTCF ZC3H4 SH3D19 EIF4B MKI67 KMT2A NOP2 HDGFL2 WDR44 | 2.39e-06 | 934 | 114 | 14 | 33916271 |
| Pubmed | 2.79e-06 | 119 | 114 | 6 | 23508102 | ||
| Pubmed | 2.84e-06 | 9 | 114 | 3 | 22665483 | ||
| Pubmed | BRD3 HMGA1 TRIP12 JARID2 ZC3H4 NCAPD2 KMT2A PHF14 HDGFL2 PHIP | 3.52e-06 | 469 | 114 | 10 | 27634302 | |
| Pubmed | Esco2 is a novel corepressor that associates with various chromatin modifying enzymes. | 4.05e-06 | 10 | 114 | 3 | 18501190 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 4.16e-06 | 33 | 114 | 4 | 26864203 | |
| Pubmed | PMS2 REPS1 MYO5A KDM5A JADE2 SPTBN1 NR4A2 AIRE MRPS35 TRIP12 STAMBP SETDB1 PIK3R1 SH3D19 SCAI BRWD1 | 4.71e-06 | 1285 | 114 | 16 | 35914814 | |
| Pubmed | RPGRIP1 ABI3BP MYO5A KDM5A SPTBN1 MRPS35 BRD3 HMGA1 SRCAP TRIP12 EIF4B NCAPD2 KMT2A PHF14 BSN PLIN1 HDGFL2 | 4.76e-06 | 1442 | 114 | 17 | 35575683 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO5A KDM5A WDR46 HMGA1 TRIP12 SH3PXD2B SCML2 SBF1 ZC3H4 EIF4B MKI67 NOP2 | 4.82e-06 | 724 | 114 | 12 | 36232890 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.30e-06 | 289 | 114 | 8 | 23752268 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPEG SPTBN1 BRD3 TRIP12 ZC3H4 EIF4B NCAPD2 KMT2A HDGFL2 KDM1A | 5.86e-06 | 497 | 114 | 10 | 36774506 |
| Pubmed | 6.31e-06 | 210 | 114 | 7 | 16565220 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.38e-06 | 394 | 114 | 9 | 27248496 | |
| Pubmed | Regulation of LSD1 histone demethylase activity by its associated factors. | 7.38e-06 | 12 | 114 | 3 | 16140033 | |
| Pubmed | 7.38e-06 | 12 | 114 | 3 | 27563068 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1B MYO5A SPTBN1 WDR46 HMGA1 MCM10 SRCAP TRIP12 SBF1 NCAPD2 MKI67 SMARCA2 SRRM2 NOP2 PHIP KDM1A | 8.98e-06 | 1353 | 114 | 16 | 29467282 |
| Pubmed | 9.76e-06 | 86 | 114 | 5 | 37253089 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.06e-05 | 150 | 114 | 6 | 28242625 | |
| Pubmed | Evidence for RPGRIP1 gene as risk factor for primary open angle glaucoma. | 1.07e-05 | 2 | 114 | 2 | 21224891 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 34405474 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16573167 | ||
| Pubmed | Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter. | 1.07e-05 | 2 | 114 | 2 | 18937643 | |
| Pubmed | High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression. | 1.07e-05 | 2 | 114 | 2 | 18279675 | |
| Pubmed | KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. | 1.07e-05 | 2 | 114 | 2 | 28723559 | |
| Pubmed | Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. | 1.07e-05 | 2 | 114 | 2 | 26970896 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 15256438 | ||
| Pubmed | PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene. | 1.07e-05 | 2 | 114 | 2 | 37534630 | |
| Pubmed | Immunohistochemical expression of RBP2 and LSD1 in papillary thyroid carcinoma. | 1.07e-05 | 2 | 114 | 2 | 24068396 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24452592 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16636057 | ||
| Pubmed | Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL. | 1.07e-05 | 2 | 114 | 2 | 31916644 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 16339905 | ||
| Pubmed | 1.22e-05 | 14 | 114 | 3 | 28981838 | ||
| Pubmed | 1.34e-05 | 44 | 114 | 4 | 24183668 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.37e-05 | 157 | 114 | 6 | 30686591 | |
| Pubmed | 1.52e-05 | 15 | 114 | 3 | 35907431 | ||
| Pubmed | 1.52e-05 | 15 | 114 | 3 | 25762221 | ||
| Pubmed | Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip. | 1.59e-05 | 95 | 114 | 5 | 21440680 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.70e-05 | 163 | 114 | 6 | 22113938 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 1.83e-05 | 450 | 114 | 9 | 16751776 | |
| Pubmed | 1.86e-05 | 16 | 114 | 3 | 23870121 | ||
| Pubmed | 1.94e-05 | 99 | 114 | 5 | 34161765 | ||
| Pubmed | 2.00e-05 | 251 | 114 | 7 | 31076518 | ||
| Pubmed | 2.07e-05 | 49 | 114 | 4 | 34368113 | ||
| Pubmed | KMT2B JADE2 NOL12 BRD3 TRIP12 TBC1D10C CTCF ZC3H4 MKI67 KMT2A SRRM2 NOP2 | 2.30e-05 | 847 | 114 | 12 | 35850772 | |
| Pubmed | 2.70e-05 | 177 | 114 | 6 | 26206133 | ||
| Pubmed | SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells. | 3.19e-05 | 3 | 114 | 2 | 28381543 | |
| Pubmed | Intragraft iNOS induction during human liver allograft rejection depresses cytochrome p450 activity. | 3.19e-05 | 3 | 114 | 2 | 15349722 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 22110129 | ||
| Pubmed | Association of SET domain and myotubularin-related proteins modulates growth control. | 3.19e-05 | 3 | 114 | 2 | 9537414 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 7490103 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 33477970 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 30105513 | ||
| Pubmed | Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. | 3.19e-05 | 3 | 114 | 2 | 15071500 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 8327517 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 11783017 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24190971 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24658378 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 26431491 | ||
| Pubmed | Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development. | 3.19e-05 | 3 | 114 | 2 | 25018020 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 17558407 | ||
| Pubmed | 3.26e-05 | 183 | 114 | 6 | 36129980 | ||
| Pubmed | 3.34e-05 | 486 | 114 | 9 | 20936779 | ||
| Interaction | H2BC21 interactions | BRPF3 RIN3 KMT2B AIRE HMGA1 XRCC1 RREB1 SRCAP TRIP12 CCNF SCML2 ZZZ3 ZC3H4 MKI67 KMT2A INTS9 PHF14 SRRM2 NOP2 PHIP KDM1A CBX2 | 2.19e-11 | 696 | 110 | 22 | int:H2BC21 |
| Interaction | H3C1 interactions | SETD1B KMT2B PHF20 KDM5A WDR46 AIRE MRPS35 BRD3 HMGA1 XRCC1 SRCAP TRIP12 PIKFYVE SETDB1 CTCF ZC3H4 MKI67 SMARCA2 KMT2A NOP2 HDGFL2 PHIP KDM1A CBX2 | 8.15e-11 | 901 | 110 | 24 | int:H3C1 |
| Interaction | CBX3 interactions | BRPF3 KMT2B BRD3 HMGA1 XRCC1 RREB1 USP37 TRIP12 CCNF SETDB1 SCML2 ZC3H4 PIK3R1 MKI67 KMT2A SRRM2 HDGFL2 PHIP KDM1A SCAI | 2.90e-10 | 646 | 110 | 20 | int:CBX3 |
| Interaction | CSNK2A2 interactions | BRPF3 JADE2 WDR46 GPATCH2 BRD3 HMGA1 XRCC1 MCM10 CCNF SBF1 ZC3H4 MKI67 KMT2A INTS9 PHF14 SRRM2 NOP2 HDGFL2 KDM1A CBX2 | 1.81e-09 | 718 | 110 | 20 | int:CSNK2A2 |
| Interaction | H2BC8 interactions | PMS2 KMT2B BRD3 HMGA1 XRCC1 MCM10 RREB1 SRCAP TRIP12 SCML2 CTCF MKI67 KMT2A PHF14 HDGFL2 PHIP KDM1A CBX2 | 2.16e-09 | 576 | 110 | 18 | int:H2BC8 |
| Interaction | H3-3A interactions | SETD1B KMT2B KDM5A BRD3 HMGA1 XRCC1 MCM10 RREB1 SRCAP TRIP12 CCNF SCML2 MKI67 KMT2A PHF14 HDGFL2 PHIP KDM1A CBX2 BRWD1 | 3.71e-09 | 749 | 110 | 20 | int:H3-3A |
| Interaction | CENPA interactions | KMT2B BRD3 HMGA1 MCM10 RREB1 TRIP12 SMARCA2 KMT2A PHF14 NOP2 HDGFL2 PHIP CBX2 BRWD1 | 1.83e-08 | 377 | 110 | 14 | int:CENPA |
| Interaction | YEATS2 interactions | 3.00e-08 | 169 | 110 | 10 | int:YEATS2 | |
| Interaction | TERF2IP interactions | KMT2B XRCC1 MCM10 RREB1 SRCAP TRIP12 KBTBD7 ZZZ3 CTCF ZC3H4 MKI67 KMT2A INTS9 SRRM2 KDM1A CBX2 | 5.24e-08 | 552 | 110 | 16 | int:TERF2IP |
| Interaction | H3C3 interactions | KMT2B KDM5A BRD3 RREB1 SRCAP TRIP12 SCML2 MKI67 KMT2A PHF14 NOP2 HDGFL2 PHIP KDM1A CBX2 | 8.01e-08 | 495 | 110 | 15 | int:H3C3 |
| Interaction | KMT2A interactions | SETD1B KMT2B PHF20 KDM5A BRD3 HMGA1 ZZZ3 SBF1 SETBP1 MKI67 SMARCA2 KMT2A | 1.49e-07 | 314 | 110 | 12 | int:KMT2A |
| Interaction | HMGN5 interactions | 1.69e-07 | 154 | 110 | 9 | int:HMGN5 | |
| Interaction | ASH2L interactions | SETD1B KMT2B PHF20 JADE2 HMGA1 SRCAP ZZZ3 ZSCAN1 SETBP1 MKI67 KMT2A | 2.23e-07 | 265 | 110 | 11 | int:ASH2L |
| Interaction | SMARCA4 interactions | PMS2 BICRA NR4A2 BRD3 HMGA1 SRCAP CCNF SCML2 CTCF PIK3R1 SMARCA2 SRRM2 PHIP BRWD1 | 2.25e-07 | 462 | 110 | 14 | int:SMARCA4 |
| Interaction | NUMA1 interactions | BRD3 HMGA1 XRCC1 SRCAP TRIP12 SHANK3 CCNF SETDB1 MKI67 SMARCA2 KMT2A PHF14 PHIP CBX2 | 2.70e-07 | 469 | 110 | 14 | int:NUMA1 |
| Interaction | PHF20 interactions | 4.29e-07 | 53 | 110 | 6 | int:PHF20 | |
| Interaction | POLR1G interactions | KMT2B BICRA BRD3 XRCC1 RREB1 SRCAP TRIP12 CTCF KMT2A PHF14 SRRM2 NOP2 PHIP CBX2 | 4.46e-07 | 489 | 110 | 14 | int:POLR1G |
| Interaction | MCRS1 interactions | 6.50e-07 | 235 | 110 | 10 | int:MCRS1 | |
| Interaction | MEN1 interactions | PMS2 SETD1B KMT2B PHF20 JADE2 NOL12 WDR46 XRCC1 SRCAP TRIP12 SCML2 CTCF ZC3H4 SETBP1 NCAPD2 MKI67 KMT2A INTS9 SRRM2 NOP2 | 6.66e-07 | 1029 | 110 | 20 | int:MEN1 |
| Interaction | ZNF608 interactions | 7.66e-07 | 93 | 110 | 7 | int:ZNF608 | |
| Interaction | RERE interactions | 7.66e-07 | 93 | 110 | 7 | int:RERE | |
| Interaction | H2AX interactions | RIN3 MRPS35 BRD3 HMGA1 XRCC1 PHF21A SCML2 CTCF MKI67 SMARCA2 PHF14 SRRM2 HDGFL2 CRAMP1 CBX2 | 8.02e-07 | 593 | 110 | 15 | int:H2AX |
| Interaction | CSNK2A1 interactions | RIN3 KMT2B JADE2 SPTBN1 GPATCH2 BRD3 HMGA1 XRCC1 SHANK3 ZC3H4 PIK3R1 EIF4B NCAPD2 KMT2A SRRM2 HDGFL2 KDM1A WDR44 CBX2 | 9.47e-07 | 956 | 110 | 19 | int:CSNK2A1 |
| Interaction | KANSL1 interactions | 9.51e-07 | 96 | 110 | 7 | int:KANSL1 | |
| Interaction | SSRP1 interactions | AIRE BRD3 XRCC1 RHOBTB1 SBF1 ZC3H4 PIK3R1 KMT2A INTS9 PHF14 SRRM2 NOP2 HDGFL2 PHIP CBX2 BRWD1 | 9.54e-07 | 685 | 110 | 16 | int:SSRP1 |
| Interaction | CHD8 interactions | 1.14e-06 | 193 | 110 | 9 | int:CHD8 | |
| Interaction | SMARCC1 interactions | BICRA BRD3 HMGA1 SRCAP CCNF RHOBTB1 NCAPD2 SMARCA2 KMT2A SRRM2 HDGFL2 KDM1A | 1.27e-06 | 384 | 110 | 12 | int:SMARCC1 |
| Interaction | CSNK2B interactions | RIN3 KMT2B RPS6KB2 GPATCH2 BRD3 XRCC1 CCDC115 SHANK3 CCNF CTCF ZC3H4 KMT2A HDGFL2 KDM1A CBX2 | 1.54e-06 | 625 | 110 | 15 | int:CSNK2B |
| Interaction | TAF1 interactions | BRPF3 PHF20 BRD3 USP37 PHF21A SMARCA2 KMT2A PHIP KDM1A BRWD1 | 1.63e-06 | 260 | 110 | 10 | int:TAF1 |
| Interaction | H3C14 interactions | 2.26e-06 | 156 | 110 | 8 | int:H3C14 | |
| Interaction | KAT14 interactions | 2.69e-06 | 112 | 110 | 7 | int:KAT14 | |
| Interaction | PHF20L1 interactions | 3.42e-06 | 75 | 110 | 6 | int:PHF20L1 | |
| Interaction | RBBP5 interactions | SETD1B KMT2B PHF20 HMGA1 ZZZ3 MKI67 SMARCA2 KMT2A SRRM2 KDM1A | 3.93e-06 | 287 | 110 | 10 | int:RBBP5 |
| Interaction | CBX1 interactions | ABI3BP BRD3 HMGA1 SETDB1 MKI67 SMARCA2 PHF14 HDGFL2 KDM1A SCAI | 4.05e-06 | 288 | 110 | 10 | int:CBX1 |
| Interaction | SETD1A interactions | 4.29e-06 | 170 | 110 | 8 | int:SETD1A | |
| Interaction | H2BC1 interactions | 6.02e-06 | 178 | 110 | 8 | int:H2BC1 | |
| Interaction | H3-4 interactions | BRPF3 KDM5A JADE2 AIRE HMGA1 RREB1 PHF21A SETDB1 KMT2A NOP2 KDM1A CBX2 | 6.18e-06 | 448 | 110 | 12 | int:H3-4 |
| Interaction | KMT2B interactions | 7.24e-06 | 130 | 110 | 7 | int:KMT2B | |
| Interaction | SMC5 interactions | BICRA HMGA1 XRCC1 RREB1 TRIP12 SCML2 ZZZ3 CTCF ZC3H4 EIF4B MKI67 KMT2A PHF14 SRRM2 NOP2 HDGFL2 PHIP CBX2 | 7.54e-06 | 1000 | 110 | 18 | int:SMC5 |
| Interaction | BCR interactions | 7.74e-06 | 244 | 110 | 9 | int:BCR | |
| Interaction | CXXC1 interactions | 8.01e-06 | 132 | 110 | 7 | int:CXXC1 | |
| Interaction | BRSK2 interactions | 1.05e-05 | 91 | 110 | 6 | int:BRSK2 | |
| Interaction | CHAF1A interactions | REPS1 BRD3 HMGA1 TRIP12 CCNF SETDB1 PIK3R1 SMARCA2 KDM1A SCAI | 1.08e-05 | 322 | 110 | 10 | int:CHAF1A |
| Interaction | ZZZ3 interactions | 1.12e-05 | 139 | 110 | 7 | int:ZZZ3 | |
| Interaction | SIRT7 interactions | MYO5A SPTBN1 WDR46 TRIP12 KBTBD7 SBF1 CTCF NCAPD2 MKI67 SMARCA2 KMT2A SRRM2 NOP2 PHIP KDM1A | 1.27e-05 | 744 | 110 | 15 | int:SIRT7 |
| Interaction | APEX1 interactions | KMT2B MYO5A SPTBN1 WDR46 OSR2 BRD3 HMGA1 XRCC1 RREB1 SRCAP TRIP12 SCML2 MVB12A TRMT44 KMT2A NOP2 HDGFL2 KDM1A CBX2 BRWD1 | 1.61e-05 | 1271 | 110 | 20 | int:APEX1 |
| Interaction | SIN3B interactions | 1.62e-05 | 147 | 110 | 7 | int:SIN3B | |
| Interaction | BRD3 interactions | BICRA BRD3 XRCC1 TRIP12 SCML2 CTCF ZC3H4 MKI67 SMARCA2 KMT2A SRRM2 PHIP | 1.64e-05 | 494 | 110 | 12 | int:BRD3 |
| Interaction | CHAMP1 interactions | 1.69e-05 | 148 | 110 | 7 | int:CHAMP1 | |
| Interaction | POU5F1 interactions | MRPS35 BRD3 EBF1 HMGA1 XRCC1 JARID2 SETDB1 SCML2 NCAPD2 SMARCA2 KDM1A CBX2 BRWD1 | 1.80e-05 | 584 | 110 | 13 | int:POU5F1 |
| Interaction | HDAC2 interactions | KDM5A AIRE HMGA1 RREB1 USP37 PHF21A CCNF JARID2 SETDB1 NCAPD2 MKI67 SMARCA2 KMT2A PHF14 SRRM2 KDM1A | 1.84e-05 | 865 | 110 | 16 | int:HDAC2 |
| Interaction | SMARCA2 interactions | BICRA NR4A2 ZKSCAN2 BRD3 MKI67 SMARCA2 KMT2A SRRM2 HDGFL2 KDM1A | 2.00e-05 | 346 | 110 | 10 | int:SMARCA2 |
| Interaction | SUMO2 interactions | SPTBN1 BRD3 RREB1 SRCAP MAST2 TRIP12 SETDB1 MYG1 NCAPD2 MKI67 SRRM2 NOP2 KDM1A | 2.04e-05 | 591 | 110 | 13 | int:SUMO2 |
| Interaction | BRD2 interactions | KDM5A BICRA NOL12 BRD3 XRCC1 JARID2 CTCF ZC3H4 SMARCA2 HDGFL2 PHIP | 2.30e-05 | 429 | 110 | 11 | int:BRD2 |
| Interaction | DAXX interactions | 2.38e-05 | 353 | 110 | 10 | int:DAXX | |
| Interaction | RPS5 interactions | PRUNE2 RIN3 NOL12 RPS6KB2 CCNF CTCF EIF4B NCAPD2 MKI67 SRRM2 NOP2 | 2.40e-05 | 431 | 110 | 11 | int:RPS5 |
| Interaction | DDB1 interactions | RIN3 PMS2 RPS6KB2 WDR46 HMGA1 MCM10 NPHP4 SHANK3 PHF21A CCNF SMARCA2 PHIP KDM1A BRWD1 | 2.63e-05 | 697 | 110 | 14 | int:DDB1 |
| Interaction | WDR5 interactions | SETD1B KMT2B PHF20 KDM5A SPTBN1 MRPS35 HMGA1 SHANK3 CCNF ZZZ3 SBF1 CTCF SETBP1 SMARCA2 KMT2A NOP2 HDGFL2 KDM1A | 2.75e-05 | 1101 | 110 | 18 | int:WDR5 |
| Interaction | YWHAH interactions | DLG5 RIN3 CARMIL2 KDM5A SPEG RPS6KB2 SPTBN1 MAST2 TRIP12 DENND2B CCNF SH3PXD2B SBF1 SH3D19 EIF4B KMT2A SRRM2 WNK3 | 2.78e-05 | 1102 | 110 | 18 | int:YWHAH |
| Interaction | NEK7 interactions | 2.91e-05 | 161 | 110 | 7 | int:NEK7 | |
| Interaction | SMARCB1 interactions | 3.09e-05 | 364 | 110 | 10 | int:SMARCB1 | |
| Interaction | RUVBL2 interactions | RIN3 PMS2 RPS6KB2 AIRE BRD3 HMGA1 SRCAP CCNF ZZZ3 EIF4B SRRM2 NOS2 KDM1A | 3.14e-05 | 616 | 110 | 13 | int:RUVBL2 |
| Interaction | ZNF330 interactions | KMT2B BRD3 HMGA1 XRCC1 RREB1 TRIP12 KMT2A PHF14 NOP2 PHIP CBX2 | 3.29e-05 | 446 | 110 | 11 | int:ZNF330 |
| Interaction | MBIP interactions | 3.41e-05 | 165 | 110 | 7 | int:MBIP | |
| Interaction | KLF3 interactions | 3.61e-05 | 228 | 110 | 8 | int:KLF3 | |
| Interaction | GTF2I interactions | 3.80e-05 | 373 | 110 | 10 | int:GTF2I | |
| Interaction | KMT2D interactions | 3.97e-05 | 169 | 110 | 7 | int:KMT2D | |
| Interaction | KANSL2 interactions | 4.03e-05 | 70 | 110 | 5 | int:KANSL2 | |
| Interaction | SNRNP40 interactions | KMT2B XRCC1 USP37 PHF21A CCNF CTCF ZC3H4 MKI67 KMT2A INTS9 SRRM2 HDGFL2 CBX2 | 4.43e-05 | 637 | 110 | 13 | int:SNRNP40 |
| Interaction | BCAT1 interactions | 4.62e-05 | 72 | 110 | 5 | int:BCAT1 | |
| Interaction | CHD4 interactions | BRD3 HMGA1 NPHP4 TRIP12 CCNF NCAPD2 MKI67 SMARCA2 KMT2A INTS9 PHF14 SRRM2 NOP2 HDGFL2 PHIP KDM1A | 4.90e-05 | 938 | 110 | 16 | int:CHD4 |
| Interaction | DRG2 interactions | 5.28e-05 | 74 | 110 | 5 | int:DRG2 | |
| Interaction | SETD1B interactions | 5.63e-05 | 75 | 110 | 5 | int:SETD1B | |
| Interaction | ELF1 interactions | 6.68e-05 | 126 | 110 | 6 | int:ELF1 | |
| Interaction | CBX8 interactions | 6.72e-05 | 249 | 110 | 8 | int:CBX8 | |
| Interaction | PIPSL interactions | 7.31e-05 | 252 | 110 | 8 | int:PIPSL | |
| Interaction | RBPJ interactions | 7.72e-05 | 254 | 110 | 8 | int:RBPJ | |
| Interaction | MED15 interactions | 8.29e-05 | 131 | 110 | 6 | int:MED15 | |
| Interaction | H2BC5 interactions | 8.46e-05 | 331 | 110 | 9 | int:H2BC5 | |
| Interaction | NPM1 interactions | RIN3 PMS2 MYO5A NOL12 RPS6KB2 BRD3 HMGA1 SHANK3 CCNF PIKFYVE CFAP54 CTCF PIK3R1 MKI67 KMT2A NOP2 NOS2 CBX2 | 8.49e-05 | 1201 | 110 | 18 | int:NPM1 |
| Interaction | KLF12 interactions | 9.48e-05 | 194 | 110 | 7 | int:KLF12 | |
| Interaction | TNIP1 interactions | DLG5 MYO5A NOL12 SPTBN1 WDR46 EMILIN2 HMGA1 XRCC1 MCM10 DENND2B SEMA4G PHF21A PIK3R1 EIF4B MKI67 SRRM2 NOP2 KDM1A | 1.00e-04 | 1217 | 110 | 18 | int:TNIP1 |
| Interaction | RBBP7 interactions | KDM5A RPS6KB2 HMGA1 CCNF JARID2 MYG1 CTCF NCAPD2 SMARCA2 KMT2A KDM1A | 1.04e-04 | 507 | 110 | 11 | int:RBBP7 |
| Interaction | KANSL3 interactions | 1.08e-04 | 86 | 110 | 5 | int:KANSL3 | |
| Interaction | TOP1 interactions | BRD3 XRCC1 SRCAP CCNF ZC3H4 MKI67 KMT2A INTS9 PHF14 CDC6 SRRM2 NOP2 CBX2 | 1.08e-04 | 696 | 110 | 13 | int:TOP1 |
| Interaction | GEMIN5 interactions | 1.09e-04 | 267 | 110 | 8 | int:GEMIN5 | |
| Interaction | KAT6A interactions | BRPF3 JADE2 NOL12 MRPS35 HMGA1 CTCF EIF4B KMT2A PHF14 CDC6 NOP2 | 1.09e-04 | 510 | 110 | 11 | int:KAT6A |
| Interaction | ADNP interactions | 1.11e-04 | 199 | 110 | 7 | int:ADNP | |
| Interaction | UHRF2 interactions | 1.15e-04 | 200 | 110 | 7 | int:UHRF2 | |
| Interaction | NHLH1 interactions | 1.21e-04 | 88 | 110 | 5 | int:NHLH1 | |
| Interaction | FEV interactions | 1.26e-04 | 203 | 110 | 7 | int:FEV | |
| Interaction | PSIP1 interactions | 1.34e-04 | 205 | 110 | 7 | int:PSIP1 | |
| Interaction | HNF4A interactions | 1.34e-04 | 275 | 110 | 8 | int:HNF4A | |
| Interaction | SMARCC2 interactions | 1.38e-04 | 353 | 110 | 9 | int:SMARCC2 | |
| Interaction | MCM3 interactions | 1.44e-04 | 355 | 110 | 9 | int:MCM3 | |
| Interaction | HCFC2 interactions | 1.49e-04 | 92 | 110 | 5 | int:HCFC2 | |
| Interaction | NUP43 interactions | SETD1B KMT2B KDM5A SRCAP TRIP12 PHF21A ZZZ3 CTCF MKI67 KMT2A SRRM2 PHIP | 1.57e-04 | 625 | 110 | 12 | int:NUP43 |
| Interaction | ZNF263 interactions | 1.68e-04 | 149 | 110 | 6 | int:ZNF263 | |
| Interaction | JADE3 interactions | 1.72e-04 | 51 | 110 | 4 | int:JADE3 | |
| Interaction | KAT8 interactions | 1.73e-04 | 95 | 110 | 5 | int:KAT8 | |
| Cytoband | 12p11 | 2.18e-04 | 9 | 114 | 2 | 12p11 | |
| Cytoband | 16p13.3 | 3.73e-04 | 244 | 114 | 5 | 16p13.3 | |
| GeneFamily | PHD finger proteins | 9.32e-11 | 90 | 73 | 9 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.03e-05 | 34 | 73 | 4 | 487 | |
| GeneFamily | Zinc fingers CXXC-type | 1.03e-03 | 12 | 73 | 2 | 136 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.28e-03 | 53 | 73 | 3 | 532 | |
| GeneFamily | AT-rich interaction domain containing | 1.63e-03 | 15 | 73 | 2 | 418 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 2.36e-03 | 18 | 73 | 2 | 498 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.19e-03 | 24 | 73 | 2 | 485 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.54e-03 | 25 | 73 | 2 | 504 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PHF20 KDM5A MAST2 TRIP12 DENND2B PHF21A PIKFYVE JARID2 SETDB1 ZZZ3 CTCF ZC3H4 SMARCA2 PHF14 PHIP | 4.67e-06 | 856 | 114 | 15 | M4500 |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-06 | 167 | 114 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 7.73e-06 | 183 | 114 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 193 | 114 | 6 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 193 | 114 | 6 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.08e-05 | 194 | 114 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.18e-05 | 197 | 114 | 6 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 197 | 114 | 6 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 1.21e-05 | 198 | 114 | 6 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.25e-05 | 199 | 114 | 6 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.28e-05 | 200 | 114 | 6 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | mLN-T_cell-cycling_gd_T|mLN / Region, Cell class and subclass | 1.28e-05 | 200 | 114 | 6 | 4efeef51f885ee8f6dd3911a536cc49e3c14da98 | |
| ToppCell | mLN-(1)_T_cell-(18)_cycling_gd_T|mLN / shred on region, Cell_type, and subtype | 1.28e-05 | 200 | 114 | 6 | e8a0a88a8344e80783931115bbe6cd5b62a4c1f7 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 142 | 114 | 5 | a88bf4bcc80206b16dcc504cc19a3380d01e34a4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-05 | 151 | 114 | 5 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-05 | 154 | 114 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 6.27e-05 | 163 | 114 | 5 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-05 | 168 | 114 | 5 | b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 171 | 114 | 5 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.86e-05 | 171 | 114 | 5 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-05 | 172 | 114 | 5 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.08e-05 | 172 | 114 | 5 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 8.30e-05 | 173 | 114 | 5 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.30e-05 | 173 | 114 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 8.53e-05 | 174 | 114 | 5 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.53e-05 | 174 | 114 | 5 | ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.76e-05 | 175 | 114 | 5 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 177 | 114 | 5 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.49e-05 | 178 | 114 | 5 | 462111b61f37338f97ac7dc6c7da1d4316b54445 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 178 | 114 | 5 | 79823d13652177de852c2acce9159049241f1d86 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 9.75e-05 | 179 | 114 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 180 | 114 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 181 | 114 | 5 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 181 | 114 | 5 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 181 | 114 | 5 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 183 | 114 | 5 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 183 | 114 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 184 | 114 | 5 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-MEP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 184 | 114 | 5 | 19d61d0ab038b7e729e13a46f88b8cf31759485d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 184 | 114 | 5 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 185b49630da61cbf45c0926d1b992943296d2a54 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-04 | 184 | 114 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 184 | 114 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-04 | 185 | 114 | 5 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.14e-04 | 185 | 114 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 186 | 114 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.20e-04 | 187 | 114 | 5 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 187 | 114 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 188 | 114 | 5 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 188 | 114 | 5 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 188 | 114 | 5 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.23e-04 | 188 | 114 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.26e-04 | 189 | 114 | 5 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.29e-04 | 190 | 114 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.29e-04 | 190 | 114 | 5 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 191 | 114 | 5 | 239300ff76f2c855b2b04d3002461158be90a01b | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.32e-04 | 191 | 114 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 191 | 114 | 5 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.32e-04 | 191 | 114 | 5 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 192 | 114 | 5 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.35e-04 | 192 | 114 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 192 | 114 | 5 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 192 | 114 | 5 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 193 | 114 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 1.39e-04 | 193 | 114 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 193 | 114 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 1.39e-04 | 193 | 114 | 5 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 193 | 114 | 5 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-04 | 193 | 114 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 194 | 114 | 5 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 194 | 114 | 5 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 194 | 114 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 194 | 114 | 5 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.42e-04 | 194 | 114 | 5 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.42e-04 | 194 | 114 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-04 | 194 | 114 | 5 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 194 | 114 | 5 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 194 | 114 | 5 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.42e-04 | 194 | 114 | 5 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 1.45e-04 | 195 | 114 | 5 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 1.45e-04 | 195 | 114 | 5 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 195 | 114 | 5 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 195 | 114 | 5 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 1.45e-04 | 195 | 114 | 5 | 731a454e45c7b610e0140312bcabaea711dcc766 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 195 | 114 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 195 | 114 | 5 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 195 | 114 | 5 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.49e-04 | 196 | 114 | 5 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 196 | 114 | 5 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-04 | 196 | 114 | 5 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-04 | 196 | 114 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 196 | 114 | 5 | ef1482f83872af72a55b6c5b5a1491e6f7f44dd7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-04 | 196 | 114 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 196 | 114 | 5 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 1.49e-04 | 196 | 114 | 5 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 196 | 114 | 5 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 197 | 114 | 5 | cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | RREB1 PHF21A CCNF PIKFYVE JARID2 ZZZ3 CTCF ZC3H4 PIK3R1 WDR44 BRWD1 | 1.49e-09 | 182 | 111 | 11 | 3887_DN |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.05e-06 | 172 | 111 | 8 | 7073_DN | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 5.02e-06 | 194 | 111 | 8 | 6417_DN | |
| Drug | kahweol | 5.45e-06 | 52 | 111 | 5 | CID000114778 | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A | 5.83e-06 | 198 | 111 | 8 | 4074_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.05e-06 | 199 | 111 | 8 | 2077_DN | |
| Drug | HTHQ | 9.27e-06 | 9 | 111 | 3 | CID000119193 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.02e-05 | 170 | 111 | 7 | 3791_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.02e-05 | 170 | 111 | 7 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.18e-05 | 172 | 111 | 7 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.26e-05 | 173 | 111 | 7 | 4458_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.35e-05 | 174 | 111 | 7 | 5940_DN | |
| Drug | AC1NR1HA | 2.36e-05 | 2 | 111 | 2 | CID005283080 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.44e-05 | 175 | 111 | 7 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.53e-05 | 176 | 111 | 7 | 2639_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.62e-05 | 177 | 111 | 7 | 1645_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.62e-05 | 177 | 111 | 7 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.72e-05 | 178 | 111 | 7 | 7245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.72e-05 | 178 | 111 | 7 | 4710_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.82e-05 | 179 | 111 | 7 | 2105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.13e-05 | 182 | 111 | 7 | 5802_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.25e-05 | 183 | 111 | 7 | 7136_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 3.48e-05 | 185 | 111 | 7 | 1114_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.60e-05 | 186 | 111 | 7 | 6874_DN | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 3.86e-05 | 188 | 111 | 7 | 7097_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 4.55e-05 | 193 | 111 | 7 | 6604_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 3779_DN | |
| Drug | Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 3475_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 6700_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 2133_DN | |
| Drug | naringenin | 5.51e-05 | 136 | 111 | 6 | CID000000932 | |
| Drug | tryptanthrin | 6.03e-05 | 16 | 111 | 3 | CID000073549 | |
| Drug | dG-C8-PhIP | 6.03e-05 | 16 | 111 | 3 | CID000132509 | |
| Drug | Melphalan | 6.33e-05 | 276 | 111 | 8 | ctd:D008558 | |
| Disease | prostate cancer (is_marker_for) | 2.03e-06 | 156 | 110 | 7 | DOID:10283 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | DLG5 NYAP2 REPS1 BICRA PERM1 EBF1 RREB1 DENND2B SEMA4G SH3PXD2B ZZZ3 PIK3R1 KMT2A KDM1A | 7.91e-06 | 914 | 110 | 14 | EFO_0004532 |
| Disease | Neurodevelopmental Disorders | 2.63e-05 | 93 | 110 | 5 | C1535926 | |
| Disease | reticulocyte count | NYAP2 BRD3 EBF1 RREB1 USP37 MAST2 DENND2B PIKFYVE ZC3H4 PIK3R1 SETBP1 SLC45A1 BSN HDGFL2 | 3.49e-05 | 1045 | 110 | 14 | EFO_0007986 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 6.82e-05 | 364 | 110 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | breast cancer (is_marker_for) | 6.99e-05 | 185 | 110 | 6 | DOID:1612 (is_marker_for) | |
| Disease | apolipoprotein A 1 measurement | NYAP2 REPS1 PERM1 BRD3 EBF1 HMGA1 CTCF ZC3H4 ZFP41 KMT2A PLIN1 PHIP | 7.85e-05 | 848 | 110 | 12 | EFO_0004614 |
| Disease | body fat percentage | 9.12e-05 | 488 | 110 | 9 | EFO_0007800 | |
| Disease | hematocrit | BRPF3 NYAP2 JADE2 GPATCH2 EBF1 RREB1 USP37 MAST2 DENND2B ZC3H4 ZNF641 BSN HDGFL2 | 1.02e-04 | 1011 | 110 | 13 | EFO_0004348 |
| Disease | mucositis (biomarker_via_orthology) | 1.37e-04 | 5 | 110 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | reticulocyte measurement | NYAP2 BRD3 EBF1 RREB1 USP37 DENND2B PIKFYVE ZC3H4 PIK3R1 SETBP1 SLC45A1 BSN HDGFL2 | 1.53e-04 | 1053 | 110 | 13 | EFO_0010700 |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.10e-04 | 31 | 110 | 3 | C1335167 | |
| Disease | sexual dimorphism measurement | BRPF3 NYAP2 KMT2B PHF20 RPS6KB2 HMGA1 PHF21A SETDB1 ZC3H4 PIK3R1 ZFP41 BSN PHIP | 2.46e-04 | 1106 | 110 | 13 | EFO_0021796 |
| Disease | cortical thickness | RIN3 NYAP2 KMT2B SPTBN1 MRPS35 EBF1 RREB1 MAST2 SH3PXD2B PIK3R1 FOXL2NB KMT2A RASL11B | 2.62e-04 | 1113 | 110 | 13 | EFO_0004840 |
| Disease | posterior thigh muscle fat infiltration measurement | 3.02e-04 | 35 | 110 | 3 | EFO_0020934 | |
| Disease | fat body mass, lean body mass | 3.80e-04 | 8 | 110 | 2 | EFO_0004995, EFO_0005409 | |
| Disease | mean platelet volume | RIN3 SETD1B PHF20 MYO5A SPTBN1 BRD3 EBF1 SRCAP DENND2B SHANK3 SETBP1 PHIP | 4.28e-04 | 1020 | 110 | 12 | EFO_0004584 |
| Disease | Schizophrenia | CYP1A2 NR4A2 HMGA1 XRCC1 SHANK3 JARID2 SETDB1 CTCF SMARCA2 KMT2A WNK3 | 4.67e-04 | 883 | 110 | 11 | C0036341 |
| Disease | transmembrane protein 9 measurement | 4.87e-04 | 9 | 110 | 2 | EFO_0803190 | |
| Disease | ejection fraction measurement | 5.58e-04 | 43 | 110 | 3 | EFO_0005527 | |
| Disease | alopecia areata (is_marker_for) | 6.08e-04 | 10 | 110 | 2 | DOID:986 (is_marker_for) | |
| Disease | coffee consumption measurement | 6.13e-04 | 182 | 110 | 5 | EFO_0006781 | |
| Disease | Liver carcinoma | 6.37e-04 | 507 | 110 | 8 | C2239176 | |
| Disease | Semantic-Pragmatic Disorder | 7.41e-04 | 11 | 110 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 7.41e-04 | 11 | 110 | 2 | C0751257 | |
| Disease | Language Delay | 7.41e-04 | 11 | 110 | 2 | C0023012 | |
| Disease | Language Development Disorders | 7.41e-04 | 11 | 110 | 2 | C0023014 | |
| Disease | Speech Delay | 7.41e-04 | 11 | 110 | 2 | C0241210 | |
| Disease | birth weight, parental genotype effect measurement | 7.80e-04 | 192 | 110 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | electrocardiography | 8.49e-04 | 530 | 110 | 8 | EFO_0004327 | |
| Disease | Medulloblastoma | 8.70e-04 | 50 | 110 | 3 | C0025149 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 8.70e-04 | 50 | 110 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 9.75e-04 | 52 | 110 | 3 | C0023452 | |
| Disease | Arthritis, Psoriatic | 1.22e-03 | 14 | 110 | 2 | C0003872 | |
| Disease | creatinine measurement | CYP1A2 NYAP2 SPEG RREB1 MAST2 STAMBP ZZZ3 PIK3R1 EIF4B SETBP1 BSN | 1.24e-03 | 995 | 110 | 11 | EFO_0004518 |
| Disease | Intellectual Disability | 1.46e-03 | 447 | 110 | 7 | C3714756 | |
| Disease | Insulin Resistance | 1.48e-03 | 60 | 110 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 1.48e-03 | 60 | 110 | 3 | C0920563 | |
| Disease | breast carcinoma | RIN3 NYAP2 PHF20 EBF1 RREB1 MAST2 PIK3R1 SETBP1 FOXL2NB SLC45A1 PHIP | 1.50e-03 | 1019 | 110 | 11 | EFO_0000305 |
| Disease | cortical surface area measurement | RIN3 NYAP2 REPS1 SPTBN1 PERM1 EBF1 RREB1 MAST2 PHF21A PIK3R1 FOXL2NB RASL11B KDM1A | 1.51e-03 | 1345 | 110 | 13 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | ZC3H12A NYAP2 SETD1B CARMIL2 KMT2B BRD3 DENND2B CCNF GPR158 ZC3H4 PIK3R1 SMARCA2 WNK3 | 1.53e-03 | 1347 | 110 | 13 | EFO_0005192 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.55e-03 | 61 | 110 | 3 | C1961102 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.60e-03 | 16 | 110 | 2 | EFO_0008297 | |
| Disease | total lipids in HDL measurement | 1.70e-03 | 63 | 110 | 3 | EFO_0022307 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.81e-03 | 17 | 110 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Profound Mental Retardation | 1.85e-03 | 139 | 110 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.85e-03 | 139 | 110 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.85e-03 | 139 | 110 | 4 | C0917816 | |
| Disease | chronic kidney disease | 1.91e-03 | 235 | 110 | 5 | EFO_0003884 | |
| Disease | lean mass-adjusted fat body mass | 2.03e-03 | 18 | 110 | 2 | EFO_0009890 | |
| Disease | Myeloid Leukemia | 2.03e-03 | 18 | 110 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.03e-03 | 18 | 110 | 2 | C0023466 | |
| Disease | waist-hip ratio | PRUNE2 CYP1A2 NYAP2 EMILIN2 EBF1 HMGA1 RREB1 TRIP12 SH3PXD2B SETBP1 PHIP SCAI | 2.08e-03 | 1226 | 110 | 12 | EFO_0004343 |
| Disease | energy expenditure measurement | 2.50e-03 | 20 | 110 | 2 | EFO_0008005 | |
| Disease | endometriosis | 2.58e-03 | 252 | 110 | 5 | EFO_0001065 | |
| Disease | myeloid white cell count | PRUNE2 DLG5 RIN3 SETD1B SPTBN1 EBF1 RREB1 MAST2 DENND2B SH3D19 | 2.67e-03 | 937 | 110 | 10 | EFO_0007988 |
| Disease | testosterone measurement | NYAP2 MYO5A JADE2 EBF1 RREB1 SRCAP ZC3H4 SMARCA2 KNDC1 C2 PHIP BRWD1 | 2.87e-03 | 1275 | 110 | 12 | EFO_0004908 |
| Disease | lean body mass | 3.02e-03 | 379 | 110 | 6 | EFO_0004995 | |
| Disease | unipolar depression, alcohol dependence | 3.13e-03 | 78 | 110 | 3 | EFO_0003761, MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGRSPKRRSLSPKPR | 346 | Q13523 | |
| VARRESGGRPIKPPK | 276 | Q15059 | |
| RKKSRVPPPPILLSR | 901 | Q96N23 | |
| LRRRKGPTKTPEPES | 101 | Q96NT0 | |
| VTPAPPPAKKRRGRP | 641 | P49711 | |
| PPAKKRRGRPPGRTN | 646 | P49711 | |
| SPVLKRRPKLEAPPS | 1381 | Q6F5E8 | |
| TPPKRSRGKPALSRV | 1031 | Q9ULD4 | |
| PAPPVTRRPKKDMRG | 426 | P78524 | |
| ALVPPPRLPTKRKAS | 121 | O43918 | |
| PRRAQDSKKPPRAPR | 181 | Q9UGY1 | |
| LRPRVPKGLKSPPEP | 31 | P05177 | |
| PPRPAQPTSGKKRKR | 556 | Q9NV88 | |
| TPKSLTRGPRDKPTP | 121 | P35228 | |
| PPKTRISNLRSEPPK | 406 | Q5HY64 | |
| RPDSPRERTPKGKPH | 31 | Q5T848 | |
| VGSARTRPKPRKLGP | 6 | Q6ZUU3 | |
| LGPESVPPPKRSRSK | 26 | Q9HB07 | |
| KNSRKRAPRSKVPPP | 711 | P06681 | |
| RKVKRTLPSPPPEEA | 2891 | Q9UPA5 | |
| SPKPLGRLRPPRESK | 701 | Q9NQC1 | |
| GLEEPKKLRPPPART | 211 | P18065 | |
| RRPKSAPSFRPKLAP | 1111 | Q8TDM6 | |
| SRTITPPAAPKPKRE | 346 | Q96BD5 | |
| GRGRKHKTTPLPPPR | 151 | Q9UMN6 | |
| RLQKSPVEKSPRPPL | 146 | Q7L590 | |
| PRGGRRPKRISKPSV | 16 | Q8WVZ9 | |
| PSRRRPRAPKEKAQP | 2661 | P46013 | |
| SSCGSRRQPPPKPKR | 131 | Q9P242 | |
| YIGRKKISPPTPKPR | 76 | P27986 | |
| SKLTPDRKPSRGRLP | 151 | Q8N2R0 | |
| PPEPKKIPIRNTRTR | 816 | O94880 | |
| PRKQPRKSPLVPRSL | 1416 | P29375 | |
| KPRGRKPKPERPPSS | 286 | Q7Z4V5 | |
| RRELEPKGPKPTAPS | 61 | Q5T1S8 | |
| KAPRPVPKPRGLSRD | 151 | Q96EY5 | |
| PVSGPKVERRPSRKP | 461 | O75161 | |
| KVERRPSRKPPTSPS | 466 | O75161 | |
| GRPPRVTKDKGPSLR | 1036 | O95248 | |
| RPGFPAVPREKPKRR | 481 | O60240 | |
| ARSRKPKKPHYIPRP | 16 | P0CG20 | |
| KGRKRPSVPPSPGRL | 1516 | Q9Y2I7 | |
| GERTPRKKEPPRASP | 56 | O60341 | |
| RKPLPPEQKATRRPV | 166 | Q14781 | |
| FPPSKPKSPRGRVRA | 186 | Q5T8R8 | |
| PSTPKRFPRQPRREK | 51 | Q6PB30 | |
| PGPKPLVRTSREPGK | 681 | P41002 | |
| SVRPQSKRPRKDPPS | 86 | Q96RY5 | |
| PRVKALPLSPRKRLG | 46 | Q99741 | |
| PRKPVPLRPGKAARD | 551 | Q8IZC6 | |
| KVIPRHPGDPERLPK | 361 | Q9UH73 | |
| SPRPLKFTEKPRPGV | 311 | Q9NSI6 | |
| KHTPRRRPEPKIIPS | 436 | Q86X45 | |
| PKSAEPPRSPLLKRV | 1391 | Q6P0Q8 | |
| GPEPPKTRRVSSLRP | 531 | Q5JRC9 | |
| PSVKTSPRKPRGRPR | 166 | Q03164 | |
| RHPPKPPRSKATERP | 826 | Q76NI1 | |
| GPKDPVKTLRPTPAR | 121 | Q9BXX0 | |
| KRRRKAAPLPGPTTA | 441 | Q9NW75 | |
| APGLPPAKRRKSESP | 1466 | Q9NZM4 | |
| KRHPKRRKCIRPSPP | 81 | Q9Y2W3 | |
| DSPGAPPRSPSRKKR | 171 | Q5SV97 | |
| LPAKKNLPTAPPRRR | 376 | Q8TB24 | |
| KEPSEVPTPKRPRGR | 46 | P17096 | |
| RGPPQRPKLNLKPRS | 326 | P23588 | |
| PKRGPRKRATVDVPP | 1216 | Q92833 | |
| PKRKRGRPPSIAPTA | 256 | Q9BVI0 | |
| RRGRLPSKPKSPQEP | 341 | P43354 | |
| RPPRRKALPPRTEKM | 46 | P82673 | |
| PEKRRTSLIPRPKSP | 211 | Q9BPW5 | |
| GPAELRPPRTTPRKK | 741 | Q8IYL2 | |
| PVPEKPKRGPRDRLS | 156 | Q96KN7 | |
| KGTTPLAPPPKPVRR | 691 | Q96D71 | |
| LAPPPKPVRRRLKSE | 696 | Q96D71 | |
| PEPKTKSRTPPRRRS | 1676 | Q9UQ35 | |
| REGRPPEPTPAKRKR | 2591 | Q9UQ35 | |
| KKPPPGERRSRSPRK | 2666 | Q9UQ35 | |
| PSPERLKNTGKRIPP | 596 | Q8WUY3 | |
| KRRGRPPAEKLSPNP | 1366 | P51531 | |
| RPPPPKLSATRRSNK | 346 | Q5HYK7 | |
| PLPIRPPSGTKKSKR | 461 | Q9UBS0 | |
| PGPRRESPRKERPKG | 61 | K7EJ46 | |
| GSKLPLRPKRSPPVI | 46 | Q6ZNX1 | |
| KRKPGRPRRSPPSML | 1516 | Q9UPS6 | |
| RPIKRGDILPPEKGR | 161 | O94844 | |
| ITPPAVKRRRGRPPK | 2851 | Q6ZRS2 | |
| SPIRSSRPPPAKRKK | 786 | P46087 | |
| SPVKPEGLRRPPSKT | 1066 | Q15047 | |
| RKRRPPSPEPSTKVS | 2096 | Q01082 | |
| RKPSLGKRHPPFRLP | 826 | Q15021 | |
| SGDRKPPERPTVPRK | 31 | Q8N8Y5 | |
| PRAPSKDKNGRRPSP | 346 | Q5D1E8 | |
| RDTGPPPPLKTRSVL | 561 | Q9NTN9 | |
| KINPRPAKFTERPRP | 306 | Q8WWQ0 | |
| ARTKAPPGRKREPPA | 621 | Q15772 | |
| GLRKDRPLPPPSSLK | 591 | Q96MK2 | |
| PEKLPGSLRKGIPRT | 766 | Q9BYB0 | |
| KSPSKPPGPNRIGRR | 41 | Q92766 | |
| RRSSRIKPPGPTAVP | 281 | Q9UQR0 | |
| PARDSRRPEPKPDKS | 571 | A1X283 | |
| EPRPPRRKPQTRGKT | 401 | Q8IV04 | |
| RPAKPPVVDRSLKPG | 226 | O95630 | |
| PPRKKAPRSKGPRES | 346 | Q8NBB4 | |
| SRPAPPPRKRKSELE | 251 | Q5JSH3 | |
| APRLTGTVEKPPRKR | 16 | Q8N9R8 | |
| SPGPPRNKKNRELRP | 41 | O15213 | |
| PRVRKAPTDPRLQKP | 1071 | Q9UPT8 | |
| SPKTPEPRRSPLGQK | 436 | P54278 | |
| SIDLPRRKKPLPPRS | 506 | Q86T82 | |
| KRPKLPAPTRTPATA | 271 | P18887 | |
| KRERRPLPKNARPSP | 186 | Q63HK3 | |
| PKTPEPRRSPLGQKR | 51 | Q68D20 | |
| STPKRRPRPKPPRTK | 461 | Q7Z7G0 | |
| PKRGPRRPKYSPPRD | 1006 | Q14669 | |
| KRGRKPRAELPPPSE | 726 | Q9Y6X0 | |
| RSRSPKKRPEPVPIQ | 46 | Q8IYH5 | |
| PPAPTRRRRGEKKPG | 721 | Q9H091 | |
| KPERDRAVLIPPKGP | 106 | Q96M66 | |
| LPPASPRRPRSFKSK | 1581 | Q9BYP7 | |
| SPGTRKRQRAPPVPK | 356 | Q96N77 | |
| SGRSVSLRKLKRPPP | 426 | Q9P206 | |
| PLTRTPAKPTKGRPG | 611 | Q9Y4I1 |